Transcode Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Transcode Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • Transcode Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 17.3M shares, a 61.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 17.3M +6.58M +61.5% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 7.27M +5.31M +272% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 5.81M -10M -63.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 627K +611K Dec 31, 2023 10-Q 2024-11-14
Q3 2023 10.7M -2.29M -17.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 1.95M -11M -85% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 15.8M +2.85M +21.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 16.2K* -12.9M Dec 31, 2022 10-K 2024-04-01
Q3 2022 13M +72.7K +0.56% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 13M +8.34M +180% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 13M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 12.9M +8.27M +178% Dec 31, 2021 10-K 2023-03-31
Q3 2021 12.9M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 4.64M Jun 30, 2021 10-Q 2021-08-23
Q4 2020 4.64M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.